Dwight A. Bellinger

Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector

Roland W. Herzog, Edmund Y. Yang, Linda B. Couto et al. · Nature Medicine · 1999 · 562 citations

Pathogenesis, Hematology, Immunology +9

Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors

Richard O. Snyder, Carol H. Miao, Leonard Meuse et al. · Nature Medicine · 1999 · 407 citations

Molecular Virology, Viral Pathogenesis, Immunology +8

Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy

Jane Mount, Roland W. Herzog, D. Michael Tillson et al. · Blood · 2002 · 332 citations

In Vivo Gene Therapy of Hemophilia B: Sustained Partial Correction in Factor IX-Deficient Dogs

Mark A. Kay, Steven Rothenberg, Charles N. Landen et al. · Science · 1993 · 306 citations

Histocompatibility, Genetics, Immunology +17

In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs.

Mark A. Kay, Charles N. Landen, S R Rothenberg et al. · Proceedings of the National Academy of Sciences · 1994 · 255 citations · Full text

Factor Ix, Immunology, Pathology +18